Evaluation the change of patients' glycosylated hemoglobin (HbA1c) after 12 weeks diet control
In this study, we provide the delivery service of Musashino T2DM diet for 12 weeks to patients with T2DM, to evaluate the effect on glycosylated hemoglobin (HbA1c), progression and compliance during study period.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
30
provide Musashino T2DM diet for 12 weeks to T2DM patients, to evaluate the effect on glycosylated hemoglobin (HbA1c), progression and compliance during study period.
NTUH
Taipei, Taiwan
the change of glycosylated hemoglobin (HbA1c)
12 weeks diet control
Time frame: 12 weeks
the change of patients' fasting blood Glucose
Time frame: 12 weeks
the change of patients' fasting serum Insulin
Time frame: 12 weeks
the change of patients' fasting serum C-peptide
Time frame: 12 weeks
the change of EuroQol EQ-5D questionnaire
Time frame: 12 weeks
the change of WHO-QoL questionnaire
Time frame: 12 weeks
the patients' compliance questionnaire
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.